Kumar, Gyanendra <br/><br/>
Intravenous Recombinant Tissue Plasminogen Activator Does Not Impact Mortality in Acute Ischemic Stroke at Any Time Point up to 6 Months: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.  [electronic resource] 

 -  CNS drugs  Aug 2015 
 - 659-67 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review 
<br/><br/><label>ISSN: </label>1179-1934 
<br/><br/><label>Standard No.: </label>10.1007/s40263-015-0265-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intravenous<br/>Brain Ischemia--drug therapy<br/>Fibrinolytic Agents--administration & dosage<br/>Humans<br/>Randomized Controlled Trials as Topic<br/>Stroke--drug therapy<br/>Time Factors<br/>Tissue Plasminogen Activator--administration & dosage<br/>Treatment Outcome